secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001564590-23-004687
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences appoints three new directors; three incumbents not standing for reelection
--------------------------------------------------------------------------------

- Stuart Duty, Thomas King, and Tom Sellig appointed to board effective March 29, 2023.
- Donald Joseph, Martin Mattingly, and Jay Moyes will not stand for reelection at June 2023 annual meeting.
- Appointments made under Cooperation Agreement with Dialectic Capital Management dated March 1, 2023.
- New directors each receive pro-rata $40K annual retainer and initial option for 24,000 shares vesting over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000156459023004687/0001564590-23-004687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000156459023004687/achv-8k_20230329.htm
  HTML page:      https://secwatch.observer/filing/0001564590-23-004687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer